相关实验视频
Updated: Jan 29, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
959
药理动力学和儿童肥胖:选择理想体型描述器的病理生理基础和挑战
Yolanda Hernández-Gago1, José Germán Sánchez-Hernández2, Pedro J Alcala Minagorre3
1Department of Hospital Pharmacy, Insular Maternal and Child University Hospital Complex, 35016 Las Palmas de Gran Canaria, Spain.
Pharmaceuticals (Basel, Switzerland)
|January 28, 2026
概括
儿童的肥胖会改变药物处理,影响药物的有效性. 需要新的策略来确定最佳的儿科药物剂量,以提高治疗安全性和疗效.
科学领域:
- 儿科药理学 儿科药理学
- 肥胖药物 肥胖药物 肥胖药物
- 临床药理动力学 临床药理动力学
背景情况:
- 儿童肥胖率正在上升,但最佳的药物剂量仍然不清楚.
- 肥胖会导致显著的生理变化,影响儿童的药物行为.
研究的目的:
- 审查肥胖儿童的病理生理变化如何影响药理动力学和药理动力学.
- 评估当前儿童肥胖药物剂量的体型描述.
主要方法:
- 在小儿肥胖症中药理动力学和药理动力学变化的文献综述.
- 在临床实践中用于药物剂量的体型描述符的分析.
主要成果:
- 肥胖会改变药物分发量 (水友性与脂友性药物) 和清除量.
- 心脏输出,蛋白质结合和器官功能的变化需要调整剂量.
- 目前的身体尺寸描述器不足以提供普遍的儿科肥胖剂量策略.
结论:
- 肥胖儿童的药理动力学和药理动力学变化需要量身定制的剂量.
- 进一步的研究对于开发基于证据的小儿肥胖剂量策略至关重要.
- 优化药物治疗方案将提高这一群体的治疗安全性和疗效.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
266
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
266
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
176
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
176
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
193
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
193
Ideal Solutions
22.4K
According to Raoult’s law, the partial vapor pressure of a solvent in a solution is equal or identical to the vapor pressure of the pure solvent multiplied by its mole fraction in the solution. However, Raoult's Law is only valid for ideal solutions. For a solution to be ideal, the solvent-solute interaction must be just as strong as a solvent-solvent or solute-solute interaction. This suggests that both the solute and the solvent would use the same amount of energy to escape to the...
22.4K
Choosing Between z and t Distribution
3.6K
The z and the Student t distribution estimate the population mean using the sample mean and standard deviation. However, to decide which distribution to use for a calculation, one needs to determine the sample size, the nature of the distribution, and whether the population standard deviation is known. If the population standard deviation is known and the population is normally distributed, or if the sample size is greater than 30, the z distribution is preferred. The Student t distribution is...
3.6K
Obesity
1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K

